Prevalence and severity of sexual dysfunction in women experiencing urinary incontinence with and without breast cancer: A matched control study

被引：0

作者：

Colombage, Udari N. ^{[1
,2
,3
]}

Soh, Sze-Ee ^{[3
,4
]}

Lin, Kuan-Yin ^{[5
,6
]}

Vincent, Amanda ^{[7
,8
]}

White, Michelle ^{[9
]}

Fox, Jane ^{[9
,10
]}

Frawley, Helena C. ^{[1
,11
,12
]}

机构：

[1] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne Sch Hlth Sci, Dept Physiotherapy, Carlton, Australia

[2] Federat Univ, Sch Hlth Sci & Psychol, Churchill, Australia

[3] Monash Univ, Dept Physiotherapy, Melbourne, Australia

[4] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Australia

[5] Natl Cheng Kung Univ, Dept Phys Therapy, Tainan, Taiwan

[6] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, Tainan, Taiwan

[7] Monash Hlth, Menopause Clin, Dept Endocrinol, Clayton, Vic, Australia

[8] Monash Univ, Monash Ctr Hlth Res & Implementat MCHRI, Sch Publ Hlth & Prevent Med, Clayton, Vic 3168, Australia

[9] Monash Hlth, Moorabbin Hosp, Breast Canc Clin, Bentleigh East, Vic 3165, Australia

[10] Monash Univ, Monash Hlth, Dept Surg, Sch Clin Sci, Melbourne, Australia

[11] Mercy Hosp Women, Allied Hlth Res, Melbourne, Australia

[12] Royal Womens Hosp, Allied Hlth Res, Melbourne, Australia

来源：

CONTINENCE REPORTS | 2022年 / 3卷

关键词：

Breast cancer; Sexual dysfunction; Urinary incontinence; INDEX FSFI; IMPACT; SYMPTOMS;

D O I：

10.1016/j.contre.2022.100012

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: Symptoms of either female sexual dysfunction (FSD) or urinary incontinence (UI) after breast cancer treatment are reported to be common. Despite this, the prevalence and severity of FSD in women who experience UI after breast cancer treatment has not been investigated. The aim of this study was to compare the prevalence and severity of FSD in women with and without breast cancer who experience UI. Methods: A secondary analysis of data from a larger cross-sectional study was undertaken. 21 pairs of sexually active women with and without breast cancer who experienced UI were matched according to age, body-mass index and parity. The severity of FSD was assessed using the Female Sexual Function Index (FSFI). Participant demographics, prevalence of FSD, and FSFI scores were reported descriptively. Differences in prevalence rate of FSD and FSFI scores between women with and without breast cancer and UI were analysed using Wilcoxon signed-rank or McNemar's tests. Results: Participants with breast cancer who experienced UI reported significantly higher rates of FSD (n = 19/21, 90%) compared to participants without breast cancer with UI (n = 10/21, 48% p = 0.0028). Participants with breast cancer and UI had a significantly lower overall FSFI score (median = 18.8, IQR = 12.5) compared to those without breast cancer with UI (median = 25.9, IQR = 10, p = 0.0096). They also reported lower arousal, less lubrication, lower satisfaction and more pain during sexual activity compared to participants without breast cancer who experienced UI. Conclusion: Participants with breast cancer who experienced UI had a higher prevalence and severity of FSD than participants without breast cancer with UI. They reported having lower arousal, lubrication, satisfaction and more pain during sexual activity. These preliminary results suggest larger studies to investigate sexual function in women with breast cancer and UI are warranted.

引用

页数：5

共 39 条

[1] Sexual Functioning Among Young Adult Cancer Patients: A 2-Year Longitudinal Study
Acquati, Chiara
Zebrack, Brad J.
Faul, Anna C.
Embry, Leanne
Aguilar, Christine
Block, Rebecca
Hayes-Lattin, Brandon
Freyer, David R.
Cole, Steve
[J]. CANCER, 2018, 124 (02) : 398 - 405
[2] AlAwlaqi A, 2017, J TURK-GER GYNECOL A, V18, P210, DOI 10.4274/jtgga.2017.0071
[3] Sexual function in women with urinary incontinence
Aslan, G
Köseoglu, H
Sadik, Ö
Gimen, S
Cihan, A
Esen, A
[J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2005, 17 (03) : 248 - 251
[4] Assad H., 2014, J. Clin. Oncol., V32, P125
[5] Sexual function in women with urinary incontinence and pelvic organ prolapse
Barber, MD
Visco, AG
Wyman, JF
Fantl, JA
Bump, RG
[J]. OBSTETRICS AND GYNECOLOGY, 2002, 99 (02) : 281 - 289
[6] Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)
Barber, MD
Walters, MD
Bump, RC
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (01) : 103 - 113
[7] The Female Sexual Functioning Index (FSFI): evaluation of acceptability, reliability, and validity in women with breast cancer
Bartula, Iris
Sherman, Kerry A.
[J]. SUPPORTIVE CARE IN CANCER, 2015, 23 (09) : 2633 - 2641
[8] Effect of parity on sexual function - An identical twin study
Botros, Sylvia M.
Abramov, Yoram
Miller, Jay-James R.
Sand, Peter K.
Gandhi, Sanjay
Nickolov, Angel
Goldberg, Roger P.
[J]. OBSTETRICS AND GYNECOLOGY, 2006, 107 (04) : 765 - 770
[9] Colombage U., 2022, Prevalence and impact of pelvic floor dysfunction in women with and without breast cancer: a cross-sectional study
[10] Prevalence and impact of bladder and bowel disorders in women with breast cancer: A systematic review with meta-analysis
Colombage, Udari N.
Lin, Kuan-Yin
Soh, Sze-Ee
Frawley, Helena C.
[J]. NEUROUROLOGY AND URODYNAMICS, 2021, 40 (01) : 15 - 27

← 1 2 3 4 →